---

• Boston, MA
• NASDAQ: ZIOP


• Contact:
  Scott Barry
  
• www.ziopharm.com

Related News

• ZIOPHARM Receives Positive Opinion for Orphan Drug Designation for Darinaparsin from European Medicines Agency
• ZIOPHARM Oncology and Intrexon Announce Worldwide Partnership for Synthetic Biology DNA-based Oncology Therapeutics
• Ziopharm Adds $50M, Pushing Internal, Partnered Programs
• ZIOPHARM and Solasia Pharma Announce License and Collaboration Agreement for Darinaparsin in Asia